Literature DB >> 26030254

Radiation esophagitis.

Diana Murro, Shriram Jakate1.   

Abstract

The esophagus is frequently exposed to radiation during treatment of advanced stages of common cancers such as lung, breast, and esophagus. However, symptomatic radiation esophagitis requiring endoscopic and histologic evaluation occurs quite rarely, affecting less than 1% of patients receiving radiation treatment. Symptoms occur acutely, generally within the first 2 months. Patients typically present with nonspecific symptoms such as dysphagia and odynophagia. Endoscopic changes such as erythema and ulceration are also nonspecific and nondiagnostic. Biopsies from affected areas show variable inflammatory changes and radiation-related atypia of endothelial and stromal cells. Such atypia mimics cytomegalovirus cytopathic changes, which are ruled out through absence of immunostaining. Radiation esophagitis is thus clinically unsuspected and endoscopically and histologically quite different from the more common and familiar radiation proctitis for which angioectasia is the predominant finding.

Entities:  

Mesh:

Year:  2015        PMID: 26030254     DOI: 10.5858/arpa.2014-0111-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  12 in total

1.  Impact of Regional Lymph Node Irradiation on Reducing Lymph Node Recurrence in Esophageal Cancer Patients.

Authors:  Shigenobu Watanabe; Ichiro Ogino; Daisuke Shigenaga; Masaharu Hata
Journal:  Cancer Diagn Progn       Date:  2022-03-03

2.  Oropharyngeal Dysphagia Evaluation Tools in Adults with Solid Malignancies Outside the Head and Neck and Upper GI Tract: A Systematic Review.

Authors:  Ciarán Kenny; Órla Gilheaney; Declan Walsh; Julie Regan
Journal:  Dysphagia       Date:  2018-04-02       Impact factor: 3.438

3.  Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer.

Authors:  Keven S Y Ji; Samantha M Thomas; Sanziana A Roman; Brian Czito; Kevin L Anderson; Jessica Frakes; Mohamed A Adam; Julie A Sosa; Timothy J Robinson
Journal:  J Gastrointest Surg       Date:  2018-10-29       Impact factor: 3.452

4.  A novel nomogram containing acute radiation esophagitis predicting radiation pneumonitis in thoracic cancer receiving radiotherapy.

Authors:  Wenjie Tang; Xiaolin Li; Haining Yu; Xiaoyang Yin; Bing Zou; Tingting Zhang; Jinlong Chen; Xindong Sun; Naifu Liu; Jinming Yu; Peng Xie
Journal:  BMC Cancer       Date:  2021-05-22       Impact factor: 4.430

Review 5.  Radiation-induced esophagitis in lung cancer.

Authors:  Sarah Baker; Alysa Fairchild
Journal:  Lung Cancer (Auckl)       Date:  2016-10-13

6.  Esophageal Stricture Following Radiation, Concurrent Immunochemotherapy, Treated With Hyperbaric Oxygen and Dilation.

Authors:  Olayinka D Ajayi; Cadman L Leggett; Sarel J Myburgh; Stephen M Hendriksen; Christopher J Logue; Joseph W Walter; Thomas C Masters; Bjorn C Westgard
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-05-27

Review 7.  Update on the management of the gastrointestinal effects of radiation.

Authors:  Hannah McCaughan; Stephen Boyle; John J McGoran
Journal:  World J Gastrointest Oncol       Date:  2021-05-15

8.  Radiation-Induced Esophagitis is Mitigated by Soy Isoflavones.

Authors:  Matthew D Fountain; Lisa M Abernathy; Fulvio Lonardo; Shoshana E Rothstein; Michael M Dominello; Christopher K Yunker; Wei Chen; Shirish Gadgeel; Michael C Joiner; Gilda G Hillman
Journal:  Front Oncol       Date:  2015-10-21       Impact factor: 6.244

Review 9.  Non gastro-esophageal reflux disease related esophagitis: an overview with a histologic diagnostic approach.

Authors:  Luca Mastracci; Federica Grillo; Paola Parente; Elettra Unti; Serena Battista; Paola Spaggiari; Michela Campora; Luca Valle; Matteo Fassan; Roberto Fiocca
Journal:  Pathologica       Date:  2020-09

10.  Evaluation of Epigallocatechin-3-Gallate as a Radioprotective Agent During Radiotherapy of Lung Cancer Patients: A 5-Year Survival Analysis of a Phase 2 Study.

Authors:  Wanqi Zhu; Yalan Zhao; Shuyu Zhang; Xiaolin Li; Ligang Xing; Hanxi Zhao; Jinming Yu
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.